Seeking Alpha

Ziopharm Oncology shares rally, company presents at conference

  • Shares of Ziopharm Oncology (ZIOP +18.2%) post double-digit gains.
  • The company presented today at the Biotech Industry Conference in New York.
  • In the presentation, ZIOP says it is "the farthest advanced at regulating gene function in vivo in humans" and notes that it expects to have "at least 8 INDs through 2015."
  • The company also says data is set to be presented "near-term" at multiple conferences. (full presentation)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs